Chinese biotechs gain as drugmakers targeted in new security bill said to mull divestments

WuXi AppTec ( OTCPK:WUXIF ) and WuXi Biologics ( OTCPK:WXIBF ), two affiliated China-based drugmakers targeted in recent national security legislation, are seeking to sell some of their assets in the U.S. and Europe, The Financial Times reported on Friday.

Shares of U.S.-listed biotechs.